These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
75 related items for PubMed ID: 2835996
1. [Characteristics of ceruloplasmin interaction with a specific receptor of human erythrocytes]. Saenko EL, Basevich VV, Iaropolov AI. Biokhimiia; 1988 Feb; 53(2):317-21. PubMed ID: 2835996 [Abstract] [Full Text] [Related]
2. Studies on receptor interaction of ceruloplasmin with human red blood cells. Saenko EL, Yaropolov AI. Biochem Int; 1990 Feb; 20(2):215-25. PubMed ID: 2156504 [Abstract] [Full Text] [Related]
3. [Ceruloplasmin receptor on human erythrocytes]. Saenko EL, Basevich VV, Iaropolov AI. Biokhimiia; 1988 Aug; 53(8):1310-5. PubMed ID: 2847818 [Abstract] [Full Text] [Related]
4. [Interaction of molecular forms of ceruloplasmin with specific membrane receptors from healthy persons and patients with hepatolenticular degeneration]. Puchkova LV, Verbina IA, Gaĭtskoki VS, Neĭfakh SA. Biokhimiia; 1991 Dec; 56(12):2261-9. PubMed ID: 1666959 [Abstract] [Full Text] [Related]
5. Reconstitution of the intercellular transfer pathway of the peptide moiety of ceruloplasmin in mammals. Puchkova LV, Sasina LK, Aleinikova TD, Zakharova ET, Gaitskhoki VS. Biochemistry (Mosc); 1997 Jul; 62(7):697-703. PubMed ID: 9331961 [Abstract] [Full Text] [Related]
6. Partial purification of the rat erythrocyte ceruloplasmin receptor monitored by an electrophoresis mobility shift assay. Stern RV, Frieden E. Anal Biochem; 1993 Jul; 212(1):221-8. PubMed ID: 8396362 [Abstract] [Full Text] [Related]
7. Molecular forms of ceruloplasmin in hepatolenticular degeneration and their interaction with human erythrocyte ceruloplasmin receptor. Puchkova LV, Verbina IA, Denezhkina VV, Vakharlovskii VG, Voitsekhovskii BL, Gaitskhoki VS, Neifakh SA. Biomed Sci; 1990 Jul; 1(5):460-6. PubMed ID: 1966785 [Abstract] [Full Text] [Related]
8. Liver endothelium binds, transports, and desialates ceruloplasmin which is then recognized by galactosyl receptors of hepatocytes. Tavassoli M. Trans Assoc Am Physicians; 1985 Jul; 98():370-7. PubMed ID: 3022446 [Abstract] [Full Text] [Related]
9. [Various properties of the ceruloplasmin receptor, isolated from human erythrocyte membranes]. Puchkova LV, Verbina IA, Denezhkina VV, Shavlovskiĭ MM, Gaĭtskoki VS, Neĭfakh SA. Biokhimiia; 1990 Dec; 55(12):2182-9. PubMed ID: 1965784 [Abstract] [Full Text] [Related]
10. The protective effect of normal and pathological (Wilson disease) ceruloplasmins on human erythrocytes. Saenko EL, Skorobogat'ko OV, Yaropolov AI. Biochem Int; 1990 Dec; 20(3):463-9. PubMed ID: 2161227 [Abstract] [Full Text] [Related]
11. Protective action of blood ceruloplasmin obtained from normal individuals on red blood cells compared with that from patients with Wilson's disease. Saenko EL, Skorobogat'ko OV, Yaropolov AI. Biomed Sci; 1990 Dec; 1(5):453-9. PubMed ID: 1966784 [Abstract] [Full Text] [Related]
12. Study of intracellular localization and traffic of newly synthesized ceruloplasmin receptor in cultured human fibroblasts. Sasina LK, Puchkova LV, Gaitskhoki VS. Biochemistry (Mosc); 1998 Oct; 63(10):1172-7. PubMed ID: 9864451 [Abstract] [Full Text] [Related]
13. Ceruloplasmin receptors of erythrocytes. Barnes G, Frieden E. Biochem Biophys Res Commun; 1984 Nov 30; 125(1):157-62. PubMed ID: 6095836 [Abstract] [Full Text] [Related]
14. Identification of ceruloplasmin receptors on the surface of human blood monocytes, granulocytes, and lymphocytes. Kataoka M, Tavassoli M. Exp Hematol; 1985 Sep 30; 13(8):806-10. PubMed ID: 2995102 [Abstract] [Full Text] [Related]
15. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets. Mais DE, Kochel PJ, Saussy DL, Halushka PV. Mol Pharmacol; 1985 Aug 30; 28(2):163-9. PubMed ID: 2991736 [Abstract] [Full Text] [Related]
16. Distinctions in beta-adrenergic receptor interactions with the magnesium-guanine nucleotide coupling proteins in turkey erythrocyte and S49 lymphoma membranes. Vauquelin G, Cech SY, André C, Strosberg AD, Maguire ME. J Cyclic Nucleotide Res; 1982 Aug 30; 8(3):149-62. PubMed ID: 6300206 [Abstract] [Full Text] [Related]
17. The protective effect of different forms of human ceruloplasmin in copper-induced lysis of red blood cells. Saenko EL, Yaropolov AI. Biochem Int; 1990 Oct 30; 22(1):57-66. PubMed ID: 2282081 [Abstract] [Full Text] [Related]
18. Interrelation between structure and protective action of normal and pathological ceruloplasmins during copper-induced lysis of red blood cells. Saenko EL, Skorobogat'ko OV, Yaropolov AI. Biochem Int; 1990 Nov 30; 22(4):749-57. PubMed ID: 1964048 [Abstract] [Full Text] [Related]
19. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Murphy LJ, Murphy LC, Vrhovsek E, Sutherland RL, Lazarus L. Cancer Res; 1984 May 30; 44(5):1963-8. PubMed ID: 6324992 [Abstract] [Full Text] [Related]
20. Differences between human and goose erythrocytes in response to phorbol esters and expression of phorbol ester receptors. Speizer LA, Atherton SE, Sando JJ. Cancer Res; 1987 Sep 15; 47(18):4830-4. PubMed ID: 3476197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]